DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Martinez E, Conget I, Lorano L, Casamitjana R, Gatell JM.
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.
AIDS. 13: 805-810 1999;
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.